Top Institutions in Retina / Ophthalmology
Leading academic ophthalmology and retina centers conduct and lead multicenter randomized controlled trials in retinal diseases, including DME and neovascular AMD, with expertise in novel drug delivery systems and anti-VEGF therapies. Their involvement in clinical trial design, patient recruitment, and translational research supports robust evaluation of new therapeutics like EYP-1901.
-
#1
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital is a world-renowned retina center with extensive expertise in clinical trials for retinal diseases including DME and AMD. Their leadership in the VERONA trial and strong clinical research infrastructure make them a top institution in sustained anti-VEGF therapy development.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology programs globally, with a strong focus on retinal diseases and clinical trials involving anti-VEGF agents and sustained drug delivery for DME and AMD.
-
#3
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear has a strong translational research program and clinical trial portfolio in retinal diseases, including DME and neovascular AMD, with expertise in anti-VEGF therapies and novel sustained-release drug delivery systems.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leading center for retinal disease research and clinical trials, with a focus on innovative therapies for diabetic retinopathy and macular edema, including sustained-release anti-VEGF agents.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a robust retina service with active involvement in clinical trials for diabetic macular edema and neovascular AMD, including studies on novel anti-VEGF agents and sustained drug delivery technologies.